Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 22, 2019 12:04PM
|
Re: 5 point MACE
|
5
|
Resverlogix Corp.
|
Mar 22, 2019 10:28AM
|
Re: AAC Poster Question on MoCA
|
2
|
Resverlogix Corp.
|
Mar 21, 2019 08:02PM
|
Re: Are there any levels tested that both placebo and treatment group could get improvement on
|
3
|
Resverlogix Corp.
|
Mar 21, 2019 04:13PM
|
Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 21, 2019 04:05PM
|
Re: Biogen/Eisai Scrap Aducanumab
|
3
|
Resverlogix Corp.
|
Mar 21, 2019 03:19PM
|
Re: ACC 2019 Abstracts
|
6
|
Resverlogix Corp.
|
Mar 21, 2019 03:10PM
|
Re: Biogen/Eisai Scrap Aducanumab
|
3
|
Resverlogix Corp.
|
Mar 21, 2019 09:46AM
|
Biogen/Eisai Scrap Aducanumab
|
7
|
Resverlogix Corp.
|
Mar 21, 2019 08:32AM
|
Re: RRR Calculation
|
3
|
Resverlogix Corp.
|
Mar 20, 2019 09:05PM
|
Re: Happy Anniversary
|
1
|
Resverlogix Corp.
|
Mar 20, 2019 03:23PM
|
Re: Happy Anniversary
|
1
|
Resverlogix Corp.
|
Mar 20, 2019 03:12PM
|
Re: Happy Anniversary
|
2
|
Resverlogix Corp.
|
Mar 20, 2019 02:33PM
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 20, 2019 12:10PM
|
Re: Happy Anniversary
|
6
|
Resverlogix Corp.
|
Mar 20, 2019 09:50AM
|
Happy Anniversary
|
3
|
Resverlogix Corp.
|
Mar 20, 2019 08:30AM
|
Re: Vacepa new
|
6
|
Resverlogix Corp.
|
Mar 19, 2019 05:58PM
|
Re: Vacepa new
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 05:32PM
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 04:09PM
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 01:21PM
|